Vanda Pharmaceuticals Inc’s recent filing unveils that its Officer Moran Kevin Patrick acquired Company’s shares for reported $13327.0 on Jul 29 ’24. In the deal valued at $5.92 per share,2,251 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Moran Kevin Patrick sold 2,251 shares, generating $13,327 in total proceeds. Upon selling the shares at $5.92, the SVP, CFO & Treasurer now owns 228,763 shares.
Before that, Polymeropoulos Mihael Hristos sold 24,288 shares. Vanda Pharmaceuticals Inc shares valued at $100,273 were divested by the President and CEO at a price of $4.13 per share. As a result of the transaction, Polymeropoulos Mihael Hristos now holds 1,871,730 shares, worth roughly $9.56 million.
Cantor Fitzgerald initiated its Vanda Pharmaceuticals Inc [VNDA] rating to an Overweight in a research note published on July 11, 2024; the price target was $11. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in late February from “a Buy” to “a Hold”. BofA Securities began covering VNDA with “Buy” recommendation on May 12, 2021. Citigroup revised its rating on January 14, 2021. It rated VNDA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of VNDA
On Tuesday, Vanda Pharmaceuticals Inc [NASDAQ:VNDA] saw its stock fall -0.39% to $5.11. Over the last five days, the stock has lost -3.77%. Vanda Pharmaceuticals Inc shares have risen nearly 21.09% since the year began. Nevertheless, the stocks have fallen -15.40% over the past one year. While a 52-week high of $6.75 was reached on 06/13/24, a 52-week low of $3.30 was recorded on 02/06/24. SMA at 50 days reached $5.77, while 200 days put it at $4.61.
Levels Of Support And Resistance For VNDA Stock
The 24-hour chart illustrates a support level at 5.04, which if violated will result in even more drops to 4.98. On the upside, there is a resistance level at 5.20. A further resistance level may holdings at 5.29. The Relative Strength Index (RSI) on the 14-day chart is 33.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.40, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.43%. Stochastics%K at 3.50% indicates the stock is a buying.
How much short interest is there in Vanda Pharmaceuticals Inc?
A steep rise in short interest was recorded in Vanda Pharmaceuticals Inc stocks on
